In this CE activity, experts in the field review innovations in imaging that can improve the diagnosis and monitoring of neovascular age-related macular degeneration and evaluate the latest updates in therapeutic regimens for the optimal long-term management of these patients.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme
- Start Date: 2024-12-31 06:00:00
- End Date: 2024-12-31 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Alimera Sciences, Inc. - Amount: 1140.6 - Is Kind Support: False Source: Astellas - Amount: 3575.43 - Is Kind Support: False Source: Ocular Therapeutix, Inc. - Amount: 1140.6 - Is Kind Support: False Source: Outlook Therapeutics - Amount: 647.12 - Is Kind Support: False Source: Regeneron Pharmaceuticals - Amount: 17197.47 - Is Kind Support: False Source: REGENXBIO Inc. - Amount: 647.12 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest